Edition:
India

Profile: Shin Nippon Biomedical Laboratories Ltd (2395.T)

2395.T on Tokyo Stock Exchange

619JPY
16 Aug 2019
Change (% chg)

¥3 (+0.49%)
Prev Close
¥616
Open
¥614
Day's High
¥626
Day's Low
¥611
Volume
307,400
Avg. Vol
499,876
52-wk High
¥980
52-wk Low
¥481

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is a Japan-based company mainly engaged in the provision of clinical trials and drug development services for pharmaceutical companies. The Company has four business segments. The Preclinical segment is engaged in the verification of the effectiveness and safety of new drugs by conducting tests on experimental animals, cells and bacteria. The Clinical segment is engaged in the verification of the effectiveness and safety of test articles on human. The Translational Research segment is involved in the research and development of pharmaceutical products and related technology, as well as the conduction of preclinical and clinical trials, among others. The Others segment is engaged in information collecting business, the sale of environmental analysis equipment, and the operation of accommodation. As of March 31, 2013, the Company had 27 subsidiaries and one associated company.

Company Address

Shin Nippon Biomedical Laboratories Ltd

28F, St Luke's Tower, 8-1, Akash
CHUO-KU   TKY   104-0044
P: +813.55655001
F: +813.55656160

Company Web Links